Nrf2 Ameliorates Atrial Fibrosis During Antithrombotic Therapy for Atrial Fibrillation by Modulating CYP2C9 Activity.

Autor: Liting Wu, Zhumeng Li, Lijuan Xu, Yingchao Fan, Delong Mao, Hanxiao Sun, Wenfang Zhuang
Zdroj: Journal of Cardiovascular Pharmacology; Oct2024, Vol. 84 Issue 4, p440-450, 11p
Databáze: Complementary Index